33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.61%
Positive revenue growth while MDB is negative. John Neff might see a notable competitive edge here.
2.34%
Positive gross profit growth while MDB is negative. John Neff would see a clear operational edge over the competitor.
-21.46%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.46%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
50.35%
Positive net income growth while MDB is negative. John Neff might see a big relative performance advantage.
52.38%
Positive EPS growth while MDB is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
52.38%
Positive diluted EPS growth while MDB is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.99%
Share count expansion well above MDB's 0.89%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.99%
Diluted share count expanding well above MDB's 0.89%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
156.52%
OCF growth above 1.5x MDB's 16.45%. David Dodd would confirm a clear edge in underlying cash generation.
142.32%
FCF growth above 1.5x MDB's 21.56%. David Dodd would verify if the firm’s strategic investments yield superior returns.
35.77%
10Y revenue/share CAGR under 50% of MDB's 232.81%. Michael Burry would suspect a lasting competitive disadvantage.
35.77%
5Y revenue/share CAGR under 50% of MDB's 277.82%. Michael Burry would suspect a significant competitive gap or product weakness.
35.77%
3Y revenue/share CAGR under 50% of MDB's 108.52%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
127.09%
10Y OCF/share CAGR at 50-75% of MDB's 198.65%. Martin Whitman might fear a structural deficiency in operational efficiency.
127.09%
Below 50% of MDB's 1383.57%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
127.09%
3Y OCF/share CAGR under 50% of MDB's 423.43%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
37.87%
Similar net income/share CAGR to MDB's 40.58%. Walter Schloss would see parallel tailwinds or expansions for both firms.
37.87%
Positive 5Y CAGR while MDB is negative. John Neff might view this as a strong mid-term relative advantage.
37.87%
Positive short-term CAGR while MDB is negative. John Neff would see a clear advantage in near-term profit trajectory.
-5.83%
Negative equity/share CAGR over 10 years while MDB stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-5.83%
Negative 5Y equity/share growth while MDB is at 283.83%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-5.83%
Negative 3Y equity/share growth while MDB is at 497.61%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.06%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
37.20%
Inventory growth of 37.20% while MDB is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
0.84%
Asset growth well under 50% of MDB's 5.74%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.04%
We have a declining book value while MDB shows 17.69%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-5.90%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.62%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
9.02%
SG&A growth well above MDB's 4.14%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.